Apostle

About:

Apostle Inc is a provider of innovative technologies and services for public health and life sciences.

Website: http://apostlebio.com

Twitter/X: ApostleInc

Top Investors: Amino Capital, Shangbay Capital, StartX (Stanford-StartX Fund), Aethan Capital

Description:

Apostle Inc is a biotechnology company in San Jose, CA, a provider of innovative technologies and services for public health and life sciences. Apostle aims to develop innovative technologies in the space of liquid biopsy - the sampling and analysis of non-solid biological tissue, primarily blood, often utilizing circulating free DNA (cfDNA) as a biomarker. Apostle’s innovations include Apostle MiniMax, a new scalable and automatable method to efficiently capture cfDNA from a standard blood draw; Apostle MagTouch, a nucleic acids isolation automation system, and Apostle MiniEnrich, a high-resolution DNA size enrichment technology using a magnetic nano-platform. Since 2020, the company has responded to the COVID-19 pandemic to help our community fight together with a high quality, low cost, fast, automated, Apostle COVID-19 Viral RNA Isolation System. Up to date, Apostle’s technology has served over 13 million people. Apostle Diagnostics a CLIA Certified, California State Licensed, CAP Accredited Clinical Laboratory, and is a clinical laboratory branch of Apostle Inc. The laboratory is co-directed by Wenqi Zeng, MD, PhD, FACMG and Charles Strom, MD, PhD, FAAP, FACMG, HCLD. The laboratory upholds the people-oriented and science-oriented service concept and is committed to serving the community and providing accurate, strict and timely clinical testing services. To date, Apostle Diagnostics has served more than 30,000 people.